NeoTX Therapeutics

About:

NeoTX Therapeutics is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.

Website: http://predictivetx.com

Top Investors: Maurice R. Greenberg, Tako Ventures, J. Tomilson Hill, NDFOS

Description:

NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.

Total Funding Amount:

$65M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rehovot, HaMerkaz, Israel

Founded Date:

2015-01-01

Founders:

Asher Nathan, Robert Harow

Number of Employees:

11-50

Last Funding Date:

2020-02-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai